Oncology Biosimilars Market Report

Japan Oncology Biosimilars Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Jun 15, 2020
  • PAGES：165
  • REPORT CODE：GMM546005
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Oncology Biosimilars market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Oncology Biosimilars market. Detailed analysis of key players, along with key growth strategies adopted by Oncology Biosimilars industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Biocon

    • BIOCAD

    • Teva Pharmaceutical Industries Ltd

    • Sandoz International GmbH

    • STADA Arzneimittel AG

    By Type:

    • G-CSF

    • Hematopoietic Agents

    • Monoclonal Antibodies

    By End-User:

    • Retail Pharmacies

    • Hospital Pharmacies

    • Online Pharmacies

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Biosimilars Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2014 to 2026

      • 1.3.2 Japan Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2014 to 2026

      • 1.3.3 Japan Oncology Biosimilars Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Market Size and Growth Rate of Retail Pharmacies

      • 1.4.2 Market Size and Growth Rate of Hospital Pharmacies

      • 1.4.3 Market Size and Growth Rate of Online Pharmacies

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Oncology Biosimilars Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncology Biosimilars by Major Types

      • 3.4.1 Japan Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2014 to 2026

      • 3.4.2 Japan Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2014 to 2026

      • 3.4.3 Japan Oncology Biosimilars Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

    4 Segmentation of Oncology Biosimilars Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncology Biosimilars by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology Biosimilars in Retail Pharmacies

      • 4.4.2 Market Size and Growth Rate of Oncology Biosimilars in Hospital Pharmacies

      • 4.4.3 Market Size and Growth Rate of Oncology Biosimilars in Online Pharmacies

    5 Market Analysis by Regions

    • 5.1 Japan Oncology Biosimilars Production Analysis by Regions

    • 5.2 Japan Oncology Biosimilars Consumption Analysis by Regions

    6 Hokkaido Oncology Biosimilars Landscape Analysis

    • 6.1 Hokkaido Oncology Biosimilars Landscape Analysis by Major Types

    • 6.2 Hokkaido Oncology Biosimilars Landscape Analysis by Major End-Users

    7 Tohoku Oncology Biosimilars Landscape Analysis

    • 7.1 Tohoku Oncology Biosimilars Landscape Analysis by Major Types

    • 7.2 Tohoku Oncology Biosimilars Landscape Analysis by Major End-Users

    8 Kanto Oncology Biosimilars Landscape Analysis

    • 8.1 Kanto Oncology Biosimilars Landscape Analysis by Major Types

    • 8.2 Kanto Oncology Biosimilars Landscape Analysis by Major End-Users

    9 Chubu Oncology Biosimilars Landscape Analysis

    • 9.1 Chubu Oncology Biosimilars Landscape Analysis by Major Types

    • 9.2 Chubu Oncology Biosimilars Landscape Analysis by Major End-Users

    10 Kinki Oncology Biosimilars Landscape Analysis

    • 10.1 Kinki Oncology Biosimilars Landscape Analysis by Major Types

    • 10.2 Kinki Oncology Biosimilars Landscape Analysis by Major End-Users

    11 Chugoku Oncology Biosimilars Landscape Analysis

    • 11.1 Chugoku Oncology Biosimilars Landscape Analysis by Major Types

    • 11.2 Chugoku Oncology Biosimilars Landscape Analysis by Major End-Users

    12 Shikoku Oncology Biosimilars Landscape Analysis

    • 12.1 Shikoku Oncology Biosimilars Landscape Analysis by Major Types

    • 12.2 Shikoku Oncology Biosimilars Landscape Analysis by Major End-Users

    13 Kyushu Oncology Biosimilars Landscape Analysis

    • 13.1 Kyushu Oncology Biosimilars Landscape Analysis by Major Types

    • 13.2 Kyushu Oncology Biosimilars Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Biocon

      • 14.1.1 Biocon Company Profile and Recent Development

      • 14.1.2 Biocon Market Performance

      • 14.1.3 Biocon Product and Service Introduction

    • 14.2 BIOCAD

      • 14.2.1 BIOCAD Company Profile and Recent Development

      • 14.2.2 BIOCAD Market Performance

      • 14.2.3 BIOCAD Product and Service Introduction

    • 14.3 Teva Pharmaceutical Industries Ltd

      • 14.3.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development

      • 14.3.2 Teva Pharmaceutical Industries Ltd Market Performance

      • 14.3.3 Teva Pharmaceutical Industries Ltd Product and Service Introduction

    • 14.4 Sandoz International GmbH

      • 14.4.1 Sandoz International GmbH Company Profile and Recent Development

      • 14.4.2 Sandoz International GmbH Market Performance

      • 14.4.3 Sandoz International GmbH Product and Service Introduction

    • 14.5 STADA Arzneimittel AG

      • 14.5.1 STADA Arzneimittel AG Company Profile and Recent Development

      • 14.5.2 STADA Arzneimittel AG Market Performance

      • 14.5.3 STADA Arzneimittel AG Product and Service Introduction

     

    The List of Tables and Figures (Totals 102 Figures and 172 Tables)

    • Figure Japan Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2014 to 2026

    • Figure Japan Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2014 to 2026

    • Figure Japan Oncology Biosimilars Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oncology Biosimilars Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oncology Biosimilars

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncology Biosimilars by Different Types from 2014 to 2026

    • Table Consumption Share of Oncology Biosimilars by Different Types from 2014 to 2026

    • Figure Japan Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2014 to 2026

    • Figure Japan Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2014 to 2026

    • Figure Japan Oncology Biosimilars Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oncology Biosimilars by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oncology Biosimilars by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table Japan Oncology Biosimilars Production by Regions

    • Table Japan Oncology Biosimilars Production Share by Regions

    • Figure Japan Oncology Biosimilars Production Share by Regions in 2014

    • Figure Japan Oncology Biosimilars Production Share by Regions in 2018

    • Figure Japan Oncology Biosimilars Production Share by Regions in 2026

    • Table Japan Oncology Biosimilars Consumption by Regions

    • Table Japan Oncology Biosimilars Consumption Share by Regions

    • Figure Japan Oncology Biosimilars Consumption Share by Regions in 2014

    • Figure Japan Oncology Biosimilars Consumption Share by Regions in 2018

    • Figure Japan Oncology Biosimilars Consumption Share by Regions in 2026

    • Table Hokkaido Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Hokkaido Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Oncology Biosimilars Consumption Share by Types in 2014

    • Figure Hokkaido Oncology Biosimilars Consumption Share by Types in 2018

    • Figure Hokkaido Oncology Biosimilars Consumption Share by Types in 2026

    • Table Hokkaido Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure Hokkaido Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure Hokkaido Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table Tohoku Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Tohoku Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Oncology Biosimilars Consumption Share by Types in 2014

    • Figure Tohoku Oncology Biosimilars Consumption Share by Types in 2018

    • Figure Tohoku Oncology Biosimilars Consumption Share by Types in 2026

    • Table Tohoku Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Tohoku Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure Tohoku Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure Tohoku Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table Kanto Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Kanto Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Kanto Oncology Biosimilars Consumption Share by Types in 2014

    • Figure Kanto Oncology Biosimilars Consumption Share by Types in 2018

    • Figure Kanto Oncology Biosimilars Consumption Share by Types in 2026

    • Table Kanto Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Kanto Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure Kanto Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure Kanto Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table Chubu Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Chubu Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Chubu Oncology Biosimilars Consumption Share by Types in 2014

    • Figure Chubu Oncology Biosimilars Consumption Share by Types in 2018

    • Figure Chubu Oncology Biosimilars Consumption Share by Types in 2026

    • Table Chubu Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Chubu Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure Chubu Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure Chubu Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table Kinki Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Kinki Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Kinki Oncology Biosimilars Consumption Share by Types in 2014

    • Figure Kinki Oncology Biosimilars Consumption Share by Types in 2018

    • Figure Kinki Oncology Biosimilars Consumption Share by Types in 2026

    • Table Kinki Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Kinki Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure Kinki Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure Kinki Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table Chugoku Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Chugoku Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Oncology Biosimilars Consumption Share by Types in 2014

    • Figure Chugoku Oncology Biosimilars Consumption Share by Types in 2018

    • Figure Chugoku Oncology Biosimilars Consumption Share by Types in 2026

    • Table Chugoku Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Chugoku Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure Chugoku Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure Chugoku Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table Shikoku Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Shikoku Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Oncology Biosimilars Consumption Share by Types in 2014

    • Figure Shikoku Oncology Biosimilars Consumption Share by Types in 2018

    • Figure Shikoku Oncology Biosimilars Consumption Share by Types in 2026

    • Table Shikoku Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Shikoku Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure Shikoku Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure Shikoku Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table Kyushu Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Kyushu Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Oncology Biosimilars Consumption Share by Types in 2014

    • Figure Kyushu Oncology Biosimilars Consumption Share by Types in 2018

    • Figure Kyushu Oncology Biosimilars Consumption Share by Types in 2026

    • Table Kyushu Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Kyushu Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure Kyushu Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure Kyushu Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of BIOCAD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOCAD

    • Figure Sales and Growth Rate Analysis of BIOCAD

    • Figure Revenue and Market Share Analysis of BIOCAD

    • Table Product and Service Introduction of BIOCAD

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd

    • Table Company Profile and Development Status of Sandoz International GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International GmbH

    • Figure Sales and Growth Rate Analysis of Sandoz International GmbH

    • Figure Revenue and Market Share Analysis of Sandoz International GmbH

    • Table Product and Service Introduction of Sandoz International GmbH

    • Table Company Profile and Development Status of STADA Arzneimittel AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of STADA Arzneimittel AG

    • Figure Sales and Growth Rate Analysis of STADA Arzneimittel AG

    • Figure Revenue and Market Share Analysis of STADA Arzneimittel AG

    • Table Product and Service Introduction of STADA Arzneimittel AG

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US